The sales-tip class' 30th winner, Benecia, who broke maiden by more than five lengths at Fairplex on Sept. 26, was subsequently disqualified from that victory due to a positive test for a banned medication.
This came to my attention when I received a final entry notification for the filly in a race at Hollywood Park on Friday; a maiden special weight.
A post-race urine sample tested by the University of California's Maddy Analytical Laboratory came back positive for Indomethacin, a Class 3 nonsteroidal anti-inflammatory. Her victory and earnings were stripped, and both trainer Mike Pender and jockey Martin Pedroza were ordered to return their earnings from the race to the Hollywood Park paymaster of purses by Dec. 13.
Benecia had already raced once among winners after her now-overturned maiden-breaker and before the disqualification, placing third in a $40,000 starter allowance on Oct. 15 at Hollywood Park.
Official winner of that September Fairplex race is now Sly Kitty.
Benecia's record (now 0-0-1 from three starts) and earnings ($3,920) have been adjusted in the comprehensive list of sales tips and their performance. I have neither energy nor inclination to go back and correct all calculations of the class' combined record and earnings in every post since the DQ.
No comments:
Post a Comment
I welcome comments, including criticism and debate. But jerks and the vulgar will not be tolerated.
Thanks!